Form 4: Privia Health Director Nancy Cocozza Receives Restricted Stock Units Grant

Privia Health Group, Inc. Director Nancy G. Cocozza was granted 8,396 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Summary

• Nancy G. Cocozza, a Director of Privia Health Group, Inc. (PRVA), acquired 8,396 shares of common stock in the form of restricted stock units (RSUs).
• The transaction occurred on May 21, 2025, with a reported price of $0 per unit, indicating a grant rather than a purchase.
• These RSUs were granted under the Issuer's 2021 Omnibus Incentive Plan.
• Following this transaction, Ms. Cocozza beneficially owns 34,351 shares directly.
• The restricted stock units will vest on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or the first anniversary of the grant date (May 21, 2026).

Sentiment

Score: 6

Explanation: The grant of restricted stock units to a director is a standard compensation practice, generally viewed as neutral to slightly positive as it aligns interests and aids retention, without indicating immediate financial distress or exceptional performance.

Positives

• The grant of restricted stock units aligns the director's interests with long-term shareholder value.
• It serves as a retention mechanism for key management and board members.

Negatives

• The issuance of new restricted stock units can lead to minor dilution for existing shareholders upon vesting.

Risks

• Potential future dilution from the vesting of these restricted stock units.

Future Outlook

The restricted stock units are set to vest on the earlier of May 21, 2026, or the day before the company's 2026 annual meeting of stockholders, indicating a future increase in the director's vested equity.

Industry Context

Insider equity grants, particularly restricted stock units, are a common form of compensation for directors and executives in publicly traded companies, aiming to align their interests with long-term company performance and shareholder value. This is a standard practice in the healthcare services industry for executive and board compensation.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor potential future dilution upon vesting of RSUs, but also improved alignment of director interests with long-term company performance.
• Employees/Management: Reflects standard compensation practices for senior leadership, potentially boosting morale and retention.

Next Steps

• Vesting of the 8,396 restricted stock units on the earlier of May 21, 2026, or the day preceding the 2026 annual meeting of stockholders.

Key Dates

Keywords

Privia Health Group, PRVA, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Director Compensation, Equity Incentive Plan, Stock Ownership